REDWOOD CITY, Calif., March 19, 2018 (GLOBE NEWSWIRE) -- OncoMed Pharmaceuticals, Inc. (NASDAQ:OMED), a clinical-stage biopharmaceutical company focused on discovering and developing novel anti-cancer therapeutics, today announced the appointment of Dr. John Lewicki as President and Chief Executive Officer of OncoMed, effective immediately. Dr. Lewicki was also appointed to the company's Board of Directors.
"John has been a key member of the OncoMed leadership team since the formation of the company, and he has guided our science to the discovery and development of all of our therapeutic candidates," said Perry Karsen, Executive Chairman of OncoMed's Board of Directors. "The OncoMed Board of Directors and I are fully confident that John's leadership as President and Chief Executive Officer will help ensure the company maximizes the value of our therapeutic candidates for cancer patients and our shareholders. We look forward to working closely with John and the entire OncoMed team to have a positive impact on cancer patients."
Read More: http://www.oncomed.com/invest/releasedetail.cfm?ReleaseID=1061305
Via: OncoMed Via: Trinity Ventures Excerpt: Via: NPR People who are diagnosed with prediabetes can delay or prevent the disease if they change their lifestyle and lose a significant amount of weight. But here's the challenge: How can people be motivated to eat healthier and move more? Increasingly, the answer might include digital medicine. Intimidating medical devices can cause anxiety for patients — in the same way that people can experience “white coat hypertension” when seeing a doctor. Via: KTAR News PHOENIX — A procedure being used in some Arizona hospitals can lower the risk of stroke or heart attack for patients with carotid artery disease. Via: Healio HOLLYWOOD, Fla. — Several new technologies are available or on the horizon to improve the outcomes of carotid artery stenting, according to a speaker at the International Symposium on Endovascular Therapy (ISET). Via: Wall Street Journal The ‘thrombectomy’ is transforming stroke care, pre-empting brain damage in many patients, but the medical establishment is far from making it standard practice Via: Newswise Loyola First Academic Medical Center in Illinois to Offer TCAR Procedure Healthcare Organizations Partner to Study Effectiveness of Virtual Diabetes Prevention Program1/31/2018
Researchers from the University of Nebraska Medical Center and Wake Forest University are collaborating with San Francisco-based Omada Health to explore the effectiveness of a virtual diabetes prevention program. What if health care were designed so that in-person visits were the second, third, or even last option for meeting routine patient needs, rather than the first? This question seems to elicit two basic responses — sometimes expressed in the same breath: “The idea will upset many physicians, who are already under duress” and “I wish my health care worked that way.” |
Archives
October 2023
|